Additionally, the titration periods can also be extended with microdoses
Compared to continued use of GLP-1s for three years, which corresponded to an 18% risk reduction, GLP-1 users who experienced interruption and subsequently resumed gained a 12% risk reduction on average
Sun et al., 2017)
Treatment Investigation of cause and elimination if possible Prognosis Excellent Physiologic Pigmentation Etiology Normal melanocyte activity Clinical Presentation Seen in all ages Symmetric distribution over many sites, gingiva most commonly Surface architecture, texture unchanged Diagnosis History Distribution Differential Diagnosis Mucosal melanotic macule Smoking-associated melanosis Superficial malignant melanoma Treatment None Prognosis Excellent Smokers Melanosis Etiology Melanin pigmentation of oral mucosa in heavy smokers May occur in up to 1 of 5 smokers, especially females taking birth control pills or hormone replacement Melanocytes stimulated by a component in tobacco smoke Clinical Presentation Brownish discoloration of alveolar and attached labial gingiva, buccal mucosa Pigmentation is diffuse and uniformly distributed

Patients experiencing brain fog typically report: Difficulty concentrating or maintaining focus on tasks Memory problems , particularly with short-term recall or word-finding Mental fatigue or feeling mentally 'sluggish' Reduced processing speed when thinking or responding Confusion or difficulty organising thoughts Lack of mental clarity , often described as thinking through a 'haze' These symptoms can range from mild and intermittent to more persistent and functionally impairing, affecting work performance, daily activities, and quality of life
Thanks, Len